Angeline Marie Finch, CNS Clinical Nurse Specialist - Adult Health Medicare: Accepting Medicare Assignments Practice Location: 1836 South Ave, La Crosse, WI 54601 Phone: 608-782-7300 |
Mindy Rae Zenke, CNS, APNP Clinical Nurse Specialist - Adult Health Medicare: Accepting Medicare Assignments Practice Location: 800 West Ave S, La Crosse, WI 54601 Phone: 608-785-0940 |
Beckie Jean Kronebusch, APRN, CNS Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 700 West Ave S, La Crosse, WI 54601 Phone: 608-392-9413 |
Ms. Debra A Day, APNP Clinical Nurse Specialist - Psych/Mental Health, Adult Medicare: Medicare Enrolled Practice Location: 300 4th St N, La Crosse, WI 54601 Phone: 608-343-2476 |
Mrs. Erica Rae Neumeister, NP Clinical Nurse Specialist - Women's Health Medicare: Accepting Medicare Assignments Practice Location: 1836 South Ave, La Crosse, WI 54601 Phone: 608-782-3000 |
Thomas C Reardon, CNS Clinical Nurse Specialist - Adult Health Medicare: Not Enrolled in Medicare Practice Location: 1836 South Ave, La Crosse, WI 54601 Phone: 608-782-7300 |
Leona J Sedlacek, CNS Clinical Nurse Specialist - Neuroscience Medicare: Not Enrolled in Medicare Practice Location: 1836 South Ave, La Crosse, WI 54601 Phone: 608-782-7300 |
Julie A Marthaler, APNP Clinical Nurse Specialist Medicare: Accepting Medicare Assignments Practice Location: 1836 South Ave, La Crosse, WI 54601 Phone: 608-782-7300 |
Carrie L Lapham, CNS Clinical Nurse Specialist Medicare: Accepting Medicare Assignments Practice Location: 1836 South Ave, La Crosse, WI 54601 Phone: 608-782-7300 |
News Archive
It is unlikely that different types of depression can be combined to one single disease called Major Depression. When testing the efficacy of antidepressants or psychotherapy, clinicians should make an attempt to specify the subtypes of depression and to combine antidepressants and psychotherapy in a sequential approach.
Achillion Pharmaceuticals, Inc., a leader in the discovery and development of small molecule drugs to combat the most challenging infectious diseases, today announced that the Company has initiated patient dosing in a Phase II clinical trial of ACH-1625 for the treatment of hepatitis C virus (HCV) infection. ACH-1625 is a potent small molecule inhibitor of HCV protease, an enzyme necessary for viral replication. The drug candidate was discovered and is being advanced by Achillion.
A multicenter randomized controlled trial performed in Germany and published in the current issue of Psychotherapy and Psychosomatics discloses new indications for overcoming trauma in children and adolescents.
Family members or friends caring for aging or disabled individuals in California are under both financial and emotional strain and are likely to face even greater burdens, given recent cuts in state support for programs and services that support in-home care, write the authors of a new policy brief by the UCLA Center for Health Policy Research.
Accumulating research indicates that melatonin has a major role in pain transmission and has an ultra-sensitizing effect. Dr. Fang Huang and colleagues from Sun Yat-sen University in China for the first time located the distribution of melatonin receptor 1 in the caudal spinal trigeminal nucleus.
› Verified 6 days ago